Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer.

Details

Ressource 1Download: 22633539_Postprint.pdf (412.11 [Ko])
State: Public
Version: author
Serval ID
serval:BIB_181C7C266EDC
Type
Article: article from journal or magazin.
Collection
Publications
Institution
Title
Selected polymorphisms in sex hormone-related genes, circulating sex hormones and risk of endometrial cancer.
Journal
Cancer Epidemiology
Author(s)
Lundin E., Wirgin I., Lukanova A., Afanasyeva Y., Krogh V., Axelsson T., Hemminki K., Clendenen T.V., Arslan A.A., Ohlson N., Sieri S., Roy N., Koenig K.L., Idahl A., Berrino F., Toniolo P., Hallmans G., Försti A., Muti P., Lenner P., Shore R.E., Zeleniuch-Jacquotte A.
ISSN
1877-783X (Electronic)
ISSN-L
1877-7821
Publication state
Published
Issued date
2012
Peer-reviewed
Oui
Volume
36
Number
5
Pages
445-452
Language
english
Notes
Publication types: Journal Article ; Research Support, N.I.H., Extramural
Abstract
BACKGROUND: The role of estrogen and progesterone in the development of endometrial cancer is well documented. Few studies have examined the association of genetic variants in sex hormone-related genes with endometrial cancer risk.
METHODS: We conducted a case-control study nested within three cohorts to examine the association of endometrial cancer risk with polymorphisms in hormone-related genes among 391 cases (92% postmenopausal at diagnosis) and 712 individually-matched controls. We also examined the association of these polymorphisms with circulating levels of sex hormones and SHBG in a cross-sectional analysis including 596 healthy postmenopausal women at blood donation (controls from this nested case-control study and from a nested case-control study of breast cancer in one of the three cohorts).
RESULTS: Adjusting for endometrial cancer risk factors, the A allele of rs4775936 in CYP19 was significantly associated (OR(per allele)=1.22, 95% CI=1.01-1.47, p(trend)=0.04), while the T allele of rs10046 was marginally associated with increased risk of endometrial cancer (OR(per allele)=1.20, 95% CI=0.99-1.45, p(trend)=0.06). PGR rs1042838 was also marginally associated with risk (OR(per allele)=1.25, 95% CI=0.96-1.61, p(trend)=0.09). No significant association was found for the other polymorphisms, i.e. CYP1B1 rs1800440 and rs1056836, UGT1A1 rs8175347, SHBG rs6259 and ESR1 rs2234693. Rs8175347 was significantly associated with postmenopausal levels of estradiol, free estradiol and estrone and rs6259 with SHBG and estradiol.
CONCLUSION: Our findings support an association between genetic variants in CYP19, and possibly PGR, and risk of endometrial cancer.
Pubmed
Web of science
Open Access
Yes
Create date
23/11/2012 21:34
Last modification date
20/08/2019 12:48
Usage data